Drug Trial Radar · NCT06122831
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Last checked: Nov 19, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
92
Planned (sponsor's estimate)
Start
Dec 12, 2023
Primary completion
Dec 2026
Study completion Apr 2027
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open, single-arm, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets combined with TQB3617 Capsules in patients with intermediate- and high-risk Myelofibrosis.
Conditions
- Myelofibrosis
Interventions
TQ05105 TabletsDrug
TQ05105 Tablets is a Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2) Inhibitor.
TQB3617 CapsulesDrug
TQB3617 Capsules is a Bromodomain and Extra-Terminal (BET) Inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximal tolerance dose (MTD)Time frame: Up to 2 years.
- Recommended phase II dose (RP2D)Time frame: Up to 2 years
- ≥35% reduction in spleen volume (SVR35)Time frame: Up to 24 weeks
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Guangxi Zhuang Autonomous Region People's Hospital
Nanning, Guangxi, China · Not yet recruiting
Cangzhou People's Hosipital
Cangzhou, Hebei, China · Not yet recruiting
Affiliated Hospital of Chengde Medical College
Chengde, Hebei, China · Not yet recruiting
North China of Science and Technology University Affiliated Hospital
Tangshan, Hebei, China · Not yet recruiting
Xingtai People's Hospital
Xingtai, Hebei, China · Not yet recruiting
The First Hospital of Harbin
Harbin, Heilongjiang, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Not yet recruiting
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, China · Not yet recruiting
Union Hospital Tongji College Huazhong Unizersity of Science And Technology
Wuhan, Hubei, China · Not yet recruiting
Wuhan University Zhongnan Hospital
Wuhan, Hubei, China · Not yet recruiting
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China · Not yet recruiting
The Public Hospital of Wuxi
Wuxi, Jiangsu, China · Not yet recruiting
The First Hospital of Jilin University
Changchun, Jilin, China · Not yet recruiting
Xi 'An Jiaotong University Second Affiliated Hospital
Xi'an, Shaanxi, China · Not yet recruiting
Tai'an City Central Hospital
Tai’an, Shandong, China · Not yet recruiting
Central Hospital Of Minhang District, Shanghai
Shanghai, Shanghai Municipality, China · Not yet recruiting
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China · Not yet recruiting
People's Hospital of Tianjin City
Tianjin, Tianjin Municipality, China · Not yet recruiting
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.